Dr. Michael F Driscoll
Claim this profileNorton Cancer Institute
Studies Bile Duct Cancer
Studies Cholangiocarcinoma
7 reported clinical trials
25 drugs studied
Area of expertise
1Bile Duct Cancer
Stage IV
Stage III
FGFR2 positive
2Cholangiocarcinoma
Stage IV
Stage III
FGFR2 positive
Affiliated Hospitals
Clinical Trials Michael F Driscoll is currently running
LSTA1 + Standard Care
for Advanced Cancers
This trial is testing a new drug called LSTA1 combined with standard treatment in patients with advanced cholangiocarcinoma. It aims to find out if this combination is safer and more effective than the standard treatment alone.
Recruiting0 awards Phase 2
Tucatinib + Trastuzumab + Chemotherapy
for Colorectal Cancer
This study is being done to find out if tucatinib with other cancer drugs works better than standard of care to treat participants with HER2 positive colorectal cancer. This study will also determine what side effects happen when participants take this combination of drugs. A side effect is anything a drug does to the body besides treating your disease. Participants in this study have colorectal cancer that has spread through the body (metastatic) and/or cannot be removed with surgery (unresectable). Participants will be assigned randomly to the tucatinib group or standard of care group. The tucatinib group will get tucatinib, trastuzumab, and mFOLFOX6. The standard of care group will get either: * mFOLFOX6 alone, * mFOLFOX6 with bevacizumab, or * mFOLFOX6 with cetuximab mFOLFOX6 is a combination of multiple drugs. All of the drugs given in this study are used to treat this type of cancer.
Recruiting2 awards Phase 3
More about Michael F Driscoll
Clinical Trial Related4 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Michael F Driscoll has experience with
- Trastuzumab
- Tucatinib
- Cisplatin/Gemcitabine
- Futibatinib
- Fruquintinib
- Placebo
Breakdown of trials Michael F Driscoll has run
Colorectal Cancer
No disease term provided.
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael F Driscoll specialize in?
Michael F Driscoll focuses on Bile Duct Cancer and Cholangiocarcinoma. In particular, much of their work with Bile Duct Cancer has involved Stage IV patients, or patients who are Stage III.
Is Michael F Driscoll currently recruiting for clinical trials?
Yes, Michael F Driscoll is currently recruiting for 2 clinical trials in Louisville Kentucky. If you're interested in participating, you should apply.
Are there any treatments that Michael F Driscoll has studied deeply?
Yes, Michael F Driscoll has studied treatments such as Trastuzumab, Tucatinib, Cisplatin/Gemcitabine.
What is the best way to schedule an appointment with Michael F Driscoll?
Apply for one of the trials that Michael F Driscoll is conducting.
What is the office address of Michael F Driscoll?
The office of Michael F Driscoll is located at: Norton Cancer Institute, Louisville, Kentucky 40217 United States. This is the address for their practice at the Norton Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.